179 related articles for article (PubMed ID: 1932669)
1. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices.
Kitano S; Wada H; Yamaga H; Hashizume M; Koyanagi N; Iwanaga T; Iso Y; Sugimachi K
J Gastroenterol Hepatol; 1991; 6(5):476-80. PubMed ID: 1932669
[TBL] [Abstract][Full Text] [Related]
2. Trial of sclerosing agents in patients with oesophageal varices.
Kitano S; Iso Y; Yamaga H; Hashizume M; Higashi H; Sugimachi K
Br J Surg; 1988 Aug; 75(8):751-3. PubMed ID: 3048533
[TBL] [Abstract][Full Text] [Related]
3. Gastric bleeding after endoscopic injection sclerotherapy for esophageal varices may be fatal.
Higashi H; Kitano S; Hashizume M; Yamaga H; Wada H; Sugimachi K
Int Surg; 1991; 76(4):214-7. PubMed ID: 1778718
[TBL] [Abstract][Full Text] [Related]
4. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.
Oho K; Iwao T; Sumino M; Toyonaga A; Tanikawa K
Endoscopy; 1995 Jun; 27(5):349-54. PubMed ID: 7588347
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: a prospective, controlled trial compared with endoscopic injection sclerotherapy.
Gotoh Y; Iwakiri R; Sakata Y; Koyama T; Noda T; Matsunaga C; Ogata SI; Ishibashi S; Sakata H; Tsunada S; Fujimoto K
J Gastroenterol Hepatol; 1999 Mar; 14(3):241-4. PubMed ID: 10197493
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
7. Injection sclerotherapy for bleeding esophageal varices in cirrhotic patients with hepatocellular carcinoma.
Ng WD; Chan YT; Ho KK; Kong CK
Gastrointest Endosc; 1989; 35(1):69-70. PubMed ID: 2537777
[No Abstract] [Full Text] [Related]
8. Human thrombin plus 5 per cent ethanolamine oleate injected to sclerose oesophageal varices: a prospective randomized trial.
Kitano S; Hashizume M; Yamaga H; Wada H; Iso Y; Iwanaga T; Sugimachi K
Br J Surg; 1989 Jul; 76(7):715-8. PubMed ID: 2765808
[TBL] [Abstract][Full Text] [Related]
9. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial.
Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K
Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917
[TBL] [Abstract][Full Text] [Related]
10. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate.
Miyazaki S; Yoshida T; Harada T; Shigemitsu T; Takeo Y; Okita K
Hepatogastroenterology; 1998; 45(22):1155-8. PubMed ID: 9756025
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of 50% alcohol and ethanolamine oleate for oesophageal sclerotherapy.
Vij JC; Kumar N; Kumar A; Anand BS; Broor SL
Indian J Gastroenterol; 1988 Oct; 7(4):211-3. PubMed ID: 3053436
[No Abstract] [Full Text] [Related]
12. Squamous cell carcinoma after endoscopic injection sclerotherapy for esophageal varices.
Kokudo N; Sanjo K; Umekita N; Harihara Y; Tada Y; Idezuki Y
Am J Gastroenterol; 1990 Jul; 85(7):861-4. PubMed ID: 2196786
[TBL] [Abstract][Full Text] [Related]
13. Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study.
Umehara M; Onda M; Tajiri T; Toba M; Yoshida H; Yamashita K
Gastrointest Endosc; 1999 Jul; 50(1):7-12. PubMed ID: 10385714
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow up of a randomized, controlled trial on prophylactic sclerotherapy of small oesophageal varices in liver cirrhosis.
Strauss E; Ribeiro MF; Albano A; Honain NZ; Maffei RA; Caly WR
J Gastroenterol Hepatol; 1999 Mar; 14(3):225-30. PubMed ID: 10197490
[TBL] [Abstract][Full Text] [Related]
15. A double-blind randomized controlled trial comparing sodium tetradecyl sulphate and ethanolamine oleate in the sclerotherapy of bleeding oesophageal varices.
Chan AC; Chung SC; Sung JY; Leung JW; Li AK
Endoscopy; 1993 Oct; 25(8):513-7. PubMed ID: 8287811
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of endoscopic injection sclerotherapy using n-butyl-2-cyanoacrylate for gastric variceal bleeding.
Ogawa K; Ishikawa S; Naritaka Y; Shimakawa T; Wagatsuma Y; Katsube A; Kajiwara T
J Gastroenterol Hepatol; 1999 Mar; 14(3):245-50. PubMed ID: 10197494
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized study comparing the effects of large and small volumes of the sclerosant 5% ethanolamine oleate injected into esophageal varices.
Iso Y; Kitano S; Iwanaga T; Koyanagi N; Sugimachi K
Endoscopy; 1988 Nov; 20(6):285-8. PubMed ID: 3229387
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating effect of sclerosant concentration.
Dowidar N; Hafez A
J Egypt Soc Parasitol; 2002 Aug; 32(2):537-49. PubMed ID: 12214931
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience.
Akahoshi T; Hashizume M; Tomikawa M; Kawanaka H; Yamaguchi S; Konishi K; Kinjo N; Maehara Y
J Gastroenterol Hepatol; 2008 Nov; 23(11):1702-9. PubMed ID: 18713295
[TBL] [Abstract][Full Text] [Related]
20. Variceal rebleeding and recurrence after endoscopic injection sclerotherapy: a prospective evaluation in 204 patients.
Krige JE; Bornman PC; Goldberg PA; Terblanche J
Arch Surg; 2000 Nov; 135(11):1315-22. PubMed ID: 11074888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
